المؤلفون: Laurent Garderet, Meral Beksac, Cecilia Isaksson, Stig Lenhoff, Xavier Poiré, Alina Tanase, Giulia Sbianchi, Soledad González Muñiz, Jenny Byrne, Jane F. Apperley, Paul Browne, Linda Koster, Simona Iacobelli, Arnon Nagler, Ibrahim Yakoub-Agha, Jiri Mayer, Cyrille Touzeau, Marek Trneny, Rocio Parody Porras, Grzegorz W. Basak, Patrick Hayden, Didier Blaise, Mariagrazia Michieli, Péter Reményi, Stefan Schönland

المساهمون: UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Service d'hématologie

المصدر: European journal of haematology, Vol. 106, no.5, p. 708-715 (2021)

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Time Factors, Cyclophosphamide, Transplantation, Autologous, autologous transplantation, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Autologous transplantation, induction regimen, kinetics of response, multiple myeloma, Duration of Therapy, Multiple Myeloma, Prognosis, Remission Induction, Treatment Outcome, Hematopoietic Stem Cell Transplantation, Dexamethasone, Multiple myeloma, Transplantation, business.industry, Bortezomib, Hematology, General Medicine, medicine.disease, Thalidomide, Settore MED/01, Regimen, 030220 oncology & carcinogenesis, business, Autologous, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7a80260a17688c2e211e496192fde2Test
https://doi.org/10.1111/ejh.13602Test

المؤلفون: Mahmoud Aljurf, Paul Browne, Simona Iacobelli, Marie Robin, Jennifer Hoek, Péter Reményi, Nicolaus Kroeger, John A. Snowden, Ibrahim Yakoub Agha, Henrik Sengeloev, Elena V. Morozova, Henric-Jan Blok, Yves Chalandon, Arnold Ganser, Arnon Nagler, Grzegorz Helbig, Riitta Niittyvuopio, Hélène Labussière Wallet, Eduardo Olavarria, Patrick Hayden, Stavroula Masouridi-Levrat, Theo de Witte, Jakob Passweg, Gwendolyn Van Gorkom

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Hematologie (9), HUS Comprehensive Cancer Center, Hematologian yksikkö, Department of Oncology

المصدر: Bone Marrow Transplantation, 57(1), 23-30. Nature Publishing Group
Masouridi-Levrat, S, Olavarria, E, Iacobelli, S, Aljurf, M, Morozova, E, Niittyvuopio, R, Sengeloev, H, Reményi, P, Helbig, G, Browne, P, Ganser, A, Nagler, A, Snowden, J A, Robin, M, Passweg, J, Van Gorkom, G, Wallet, H L, Hoek, J, Blok, H J, De Witte, T, Kroeger, N, Hayden, P, Chalandon, Y & Agha, I Y 2022, ' Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors : a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT ', Bone Marrow Transplantation, vol. 57, no. 1, pp. 23-30 . https://doi.org/10.1038/s41409-021-01472-xTest
Bone marrow transplantation, Vol. 57, No 1 (2022) pp. 23-30
Bone Marrow Transplantation
Bone Marrow Transplantation, 57, 1, pp. 23-30
Bone Marrow Transplantation, 57, 23-30

مصطلحات موضوعية: Oncology, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], NILOTINIB, Graft vs Host Disease, THERAPY, chemistry.chemical_compound, 0302 clinical medicine, PROGNOSTIC-FACTORS, ADVANCED DISEASE, hemic and lymphatic diseases, Prospective Studies, CML, ddc:616, 0303 health sciences, DASATINIB, Ponatinib, CHRONIC MYELOGENOUS LEUKEMIA, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, 3. Good health, Dasatinib, 030220 oncology & carcinogenesis, Bosutinib, medicine.drug, medicine.medical_specialty, 3122 Cancers, IMATINIB MESYLATE, Article, 03 medical and health sciences, Medical research, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, medicine, Humans, Protein Kinase Inhibitors, Chronic myeloid leukaemia, 030304 developmental biology, Transplantation, business.industry, CHRONIC-PHASE, Imatinib, medicine.disease, Imatinib mesylate, Nilotinib, chemistry, business, FOLLOW-UP, Chronic myelogenous leukemia

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff78e844b861cf75faadfac5cf13700cTest
https://cris.maastrichtuniversity.nl/en/publications/4eab7206-4d79-4109-9ce6-4da16dcc7250Test

المؤلفون: Francesca A M Kinsella, Didier Blaise, Péter Reményi, John A. Snowden, Jürgen Kuball, Marie-Thérèse Rubio, Patrice Chevallier, Etienne Daguindau, Nicolaus Kröger, Jörg Cammenga, Donal McLornan, Johan Maertens, Jean-Baptiste Mear, Damian Finnegan, Patrick Hayden, Xavier Poiré, Juan Carlos Hernández-Boluda, Vittoria Malpassuti, Tomasz Czerw, Ibrahim Yakoub-Agha, Sébastien Maury, Linda Koster, Simona Iacobelli, Emma Watz, Marie Robin

المساهمون: UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Service d'hématologie

المصدر: Bone marrow transplantation, Vol. 57, no.2, p. 261-270 (2022)
BONE MARROW TRANSPLANTATION
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

مصطلحات موضوعية: Oncology, Melphalan, Adult, medicine.medical_specialty, Transplantation Conditioning, Platelet Engraftment, medicine.medical_treatment, Immunology, Graft vs Host Disease, Hematopoietic stem cell transplantation, Lower risk, Gastroenterology, Biochemistry, Young Adult, Aged, Humans, Middle Aged, Retrospective Studies, Unrelated Donors, Hematopoietic Stem Cell Transplantation, Neoplasms, Primary Myelofibrosis, Internal medicine, Medicine, Myelofibrosis, Transplantation, business.industry, Hazard ratio, Cell Biology, Hematology, medicine.disease, Fludarabine, Regimen, Settore MED/01, Graft-versus-host disease, business, Busulfan, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b716cad90a557c3939ea2ea72cecdcTest
https://hdl.handle.net/2078.1/261776Test

المؤلفون: Hans Martin, Dietrich W. Beelen, Vicenzo Pavone, Nicolaus Kröger, Patrick Hayden, Jan J. Cornelissen, Uwe Platzbecker, Alberto Alvarez-Larrán, Arturo Pereira, Ibrahim Yakoub-Agha, Nienke Zinger, J. M. Raya, Luuk Gras, Hermann Einsele, Didier Blaise, Moniek de Witte, Tomasz Czerw, Keith Wilson, Stig Lenhoff, Jürgen Finke, Donal McLornan, William Krüger, Adriano Salaroli, Valentín García-Gutiérrez, Henrik Sengeloev, Juan Carlos Hernández-Boluda, Katja Sockel

المساهمون: Hematology

المصدر: Hernández-Boluda, J C, Pereira, A, Kröger, N, Cornelissen, J J, Finke, J, Beelen, D, de Witte, M, Wilson, K, Platzbecker, U, Sengeloev, H, Blaise, D, Einsele, H, Sockel, K, Krüger, W, Lenhoff, S, Salaroli, A, Martin, H, García-Gutiérrez, V, Pavone, V, Alvarez-Larrán, A, Raya, J M, Zinger, N, Gras, L, Hayden, P, Czerw, T, P. McLornan, D & Yakoub-Agha, I 2021, ' Allogeneic hematopoietic cell transplantation in older myelofibrosis patients : A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry ', American Journal of Hematology, vol. 96, no. 10, pp. 1186-1194 . https://doi.org/10.1002/ajh.26279Test
American Journal of Hematology, 96(10), 1186-1194. Wiley-Liss Inc.
AMERICAN JOURNAL OF HEMATOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

مصطلحات موضوعية: Male, medicine.medical_specialty, medicine.medical_treatment, Population, Medizin, Hematopoietic stem cell transplantation, Cohort Studies, Internal medicine, medicine, Humans, Transplantation, Homologous, Registries, education, Survival rate, Survival analysis, Aged, education.field_of_study, business.industry, Age Factors, Hematopoietic Stem Cell Transplantation, Hematology, Survival Analysis, Transplantation, Primary Myelofibrosis, Spain, Cohort, Female, business, Busulfan, Cohort study, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cf0f11670abe7884bbc2ed4f8438697Test

المؤلفون: Dietrich W. Beelen, Nicola Di Renzo, Nicolaas Schaap, Katja Sockel, Peter A. von dem Borne, Patrick Hayden, Zeynep Arzu Yegin, Jakob Passweg, Giulia Sbianchi, Elena V. Morozova, Marie-Thérèse Rubio, Nicolaus Kröger, Francesca Patriarca, Christine Wolschke, Ibrahim Yakoub-Agha, Donal McLornan, Paolo Bernasconi, Johannes Clausen, Tiarlan Sirait, Marie Robin, Jürgen Finke, Radovan Vrhovac, Grzegorz Helbig, Eibhlin Conneally, Wilfried Schroyens, Yves Beguin

المساهمون: Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), Università degli Studi di Roma Tor Vergata [Roma], EBMT Data Office Leiden [Leiden, TheNetherlands], University Hospital Basel [Basel], Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University Hospital Centre Zagreb, Partenaires INRAE, Medical University of Silesia (SUM), University Hospital Carl Gustav Carus [Dresden, Germany], Technische Universität Dresden = Dresden University of Technology (TU Dresden), St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Service d'Hématologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Ingénierie Moléculaire et Physiopathologie Articulaire (IMoPA), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Liège (CHU-Liège), University of Freiburg [Freiburg], Fondazione IRCCS Policlinico San Matteo [Pavia], Università degli Studi di Pavia = University of Pavia (UNIPV), Pavlov First Saint Petersburg State Medical University [St. Petersburg], Ordensklinikum Linz Elisabethinen, Leiden University Medical Center (LUMC), Universiteit Leiden, Radboud University Medical Center [Nijmegen], Antwerp University Hospital [Edegem] (UZA), Università degli Studi di Udine - University of Udine [Italie], Gazi University, Trinity College Dublin, Guy's Hospital [London], Institute for Translational Research in Inflammation - U 1286 (INFINITE (Ex-Liric)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)

المصدر: Leukemia
Leukemia, 35, 3551-3560. SPRINGERNATURE
Leukemia, 2021, 35 (12), pp.3551-3560. ⟨10.1038/s41375-021-01276-4⟩
Leukemia, 35, 12, pp. 3551-3560
Leukemia, 35, 3551-3560

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, Ruxolitinib, medicine.medical_specialty, medicine.medical_treatment, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], [SDV]Life Sciences [q-bio], Medizin, Graft vs Host Disease, Spleen, [SDV.CAN]Life Sciences [q-bio]/Cancer, Hematopoietic stem cell transplantation, Lower risk, Article, Myeloproliferative disease, ruxolitinib, allogeneic stem cell transplantation, myelofibrosis, Recurrence, Internal medicine, Nitriles, medicine, Humans, Janus Kinase Inhibitors, Myelofibrosis, Aged, Retrospective Studies, business.industry, Significant difference, Hematopoietic Stem Cell Transplantation, Hematology, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, Middle Aged, Translational research, medicine.disease, HLA Mismatch, Transplantation, Survival Rate, medicine.anatomical_structure, Pyrimidines, Treatment Outcome, Primary Myelofibrosis, Pyrazoles, Female, Human medicine, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212303e866b3dd2753322399dfbf4659Test
https://www.ncbi.nlm.nih.gov/pubmed/34023851Test

المؤلفون: Ibrahim Yakoub-Agha, Corrado Tarella, Linda Koster, Emanuele Angelucci, Nicolaus Kröger, Fabio Ciceri, Andrew M. McDonald, Yener Koc, Meral Beksac, Concepcion Herrera Arroyo, Dirk-Jan Eikema, Goda Choi, Ellen Meijer, Johanna Tischer, Luigi Rigacci, Firoozeh Sahebi, Patrick Hayden, Jaime Sanz Caballer, Stefan Schönland, Didier Blaise, Montserrat Rovira, Noel Milpied, David Valcárcel, Friedrich Stoelzel, Luca Castagna

المصدر: Blood, 136. AMER SOC HEMATOLOGY

مصطلحات موضوعية: medicine.medical_specialty, Neutrophil Engraftment, Cyclophosphamide, Platelet Engraftment, business.industry, Immunology, Context (language use), Cell Biology, Hematology, medicine.disease, Biochemistry, Transplantation, Internal medicine, medicine, Cumulative incidence, Progression-free survival, business, Multiple myeloma, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::687293ef3a13c44c05829e19f4be224bTest
https://research.rug.nl/en/publications/b17f9094-cba5-4b80-8e63-796226a8a435Test

المؤلفون: Stefan Schönland, Patrick Hayden, Curly Morris, Meral Beksac, Gösta Gahrton, Ibrahim Yakoub-Agha, Laurent Garderet

المساهمون: Centre de Recherche Saint-Antoine (CRSA), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Queen's University [Belfast] (QUB), Ankara University School of Medicine [Turkey], Karolinska Institutet [Stockholm], Heidelberg University Hospital [Heidelberg], Institute for Translational Research in Inflammation - U 1286 (INFINITE (Ex-Liric)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Trinity College Dublin, Centre de Recherche Saint-Antoine (CR Saint-Antoine), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service d'Hématologie Biologique [CHU Pitié-Salpêtrière], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)

المصدر: Biology of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, 2020, 26 (9), pp.1559-1566. ⟨10.1016/j.bbmt.2020.04.016⟩
Biology of Blood and Marrow Transplantation, Elsevier, 2020, 26 (9), pp.1559-1566. ⟨10.1016/j.bbmt.2020.04.016⟩

مصطلحات موضوعية: Melphalan, Oncology, medicine.medical_specialty, medicine.drug_class, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Myeloma, Autologous stem cell transplantation, Monoclonal antibody, Transplantation, Autologous, 03 medical and health sciences, 0302 clinical medicine, Autologous stem-cell transplantation, Internal medicine, medicine, Humans, Transplantation, CAR T cells, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, Immunotherapy, Chimeric antigen receptor, 3. Good health, First relapse, Pharmaceutical Preparations, Novel agents, 030220 oncology & carcinogenesis, Stem cell, business, Multiple Myeloma, 030215 immunology, medicine.drug, Stem Cell Transplantation

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b0c69af4bb021f38e0e2c81be8f688Test
https://hal.sorbonne-universite.fr/hal-02969044/documentTest

المؤلفون: Giuseppe Marotta, Didier Blaise, Matjaz Sever, Patrizia Chiusolo, Ibrahim Yakoub-Agha, Tomasz Czerw, Carlos Solano, Giorgia Battipaglia, Nicolaus Kröger, Stella Santarone, Marie-Thérèse Rubio, Maria Laura Fox, Anna Paola Iori, William Arcese, Patrick Hayden, Mohamad Mohty, Liesbeth C. de Wreede, Yves Chalandon, Lotus Wendel, Juan Carlos Hernández-Boluda, Renato Fanin, Pietro Pioltelli, Emanuele Angelucci, Donal P. McLornan, Katya Mauff, Nathalie Contentin

المساهمون: University of Naples Federico II = Università degli studi di Napoli Federico II, European Society for Blood and Marrow Transplantation (EBMT), Ospedale Policlinico San Martino [Genoa], CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Università degli Studi di Roma Tor Vergata [Roma], Service d'Hématologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Ingénierie Moléculaire et Physiopathologie Articulaire (IMoPA), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Vall d'Hebron Institute of Oncology [Barcelone] (VHIO), Vall d'Hebron University Hospital [Barcelona], Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome] (UNIROMA), Università degli Studi di Udine - University of Udine [Italie], Hôpitaux Universitaires de Genève (HUG), Azienda Ospedaliera Universitaria Senese, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università cattolica del Sacro Cuore = Catholic University of the Sacred Heart [Roma] (Unicatt), University Medical Centre Ljubljana [Ljubljana, Slovenia] (UMCL), University of Ljubljana, Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Leiden University Medical Center (LUMC), Universiteit Leiden, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (MCMCC), Trinity College Dublin, NHS Foundation Trust [London], The Royal Marsden, Institute for Translational Research in Inflammation - U 1286 (INFINITE (Ex-Liric)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)

المصدر: Bone marrow transplantation, Vol. 56, No 7 (2021) pp. 1593-1602
Bone Marrow Transplantation
Bone Marrow Transplantation, 2021, 56 (7), pp.1593-1602. ⟨10.1038/s41409-021-01222-z⟩
BONE MARROW TRANSPLANTATION
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Bone Marrow Transplantation, 56(7), 1593-1602. SPRINGERNATURE

مصطلحات موضوعية: medicine.medical_specialty, Transplantation Conditioning, Platelet Engraftment, [SDV]Life Sciences [q-bio], Vidarabine / analogs & derivatives, Graft vs Host Disease, ThioTEPA, Gastroenterology, Conditioning regimen, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Neoplasms, medicine, Humans, In patient, Vidarabine / therapeutic use, Myelofibrosis, Busulfan, ComputingMilieux_MISCELLANEOUS, Retrospective Studies, ddc:616, Transplantation, Hematopoietic cell, business.industry, Hematopoietic Stem Cell Transplantation, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, Hematology, Middle Aged, Settore MED/15, medicine.disease, surgical procedures, operative, Primary Myelofibrosis, 030220 oncology & carcinogenesis, Stem cell, business, Thiotepa, Vidarabine, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d73649f9521075c90921f0f30126ed85Test
https://pubmed.ncbi.nlm.nih.gov/33526919Test

المؤلفون: Firoozeh Sahebi, Jaap van Doesum, Emanuele Angelucci, Fabio Ciceri, Anna Proia, Yener Koc, Didier Blaise, Edouard Forcade, Montserrat Rovira, Simona Sammassimo, Meral Beksac, Linda Koster, Nicolaus Kröger, David Valcárcel, Dirk-Jan Eikema, Friedrich Stölzel, Stefan Schönland, I. Yakoub-Agha, Johanna Tischer, Concepcion Herrera Arroyo, Jaime Sanz, Patrick Hayden, Luca Castagna, James F. Sanchez, Andrew McDonald, Ellen Meijer

المساهمون: Hematology, CCA - Cancer Treatment and quality of life, Sahebi, F., Eikema, D. -J., Koster, L., Kroger, N., Meijer, E., van Doesum, J. A., Rovira, M., Koc, Y., Angelucci, E., Blaise, D., Sammassimo, S., Mcdonald, A., Arroyo, C. H., Sanchez, J. F., Forcade, E., Castagna, L., Stolzel, F., Sanz, J., Tischer, J., Ciceri, F., Valcarcel, D., Proia, A., Hayden, P. J., Beksac, M., Yakoub-Agha, I., Schonland, S.

المصدر: Sahebi, F, Eikema, D-J, Koster, L, Kroger, N, Meijer, E, van Doesum, J A, Rovira, M, Koc, Y, Angelucci, E, Blaise, D, Sammassimo, S, McDonald, A, Arroyo, C H, Sanchez, J F, Forcade, E, Castagna, L, Stölzel, F, Sanz, J, Tischer, J, Ciceri, F, Valcarcel, D, Proia, A, Hayden, P J, Beksac, M, Yakoub-Agha, I & Schönland, S 2021, ' Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation : First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation: F. Sahebi et al ', Transplantation and Cellular Therapy, vol. 27, no. 12, pp. 999.e1-999.e10 . https://doi.org/10.1016/j.jtct.2021.09.008Test
Transplantation and cellular therapy, 27(12), 999.e1-999.e10
Transplantation and Cellular Therapy, 27(12), 999.e1-999.e10. Elsevier BV

مصطلحات موضوعية: medicine.medical_specialty, Platelet Engraftment, Cyclophosphamide, Graft vs Host Disease, Gastroenterology, Bone Marrow, Internal medicine, medicine, Immunology and Allergy, Humans, Cumulative incidence, Multiple myeloma, Retrospective Studies, Hematology, business.industry, hematology, Hematopoietic Stem Cell Transplantation, Cell Biology, medicine.disease, United States, Transplantation, Calcineurin, multiple myeloma, Graft-versus-host disease, surgical procedures, operative, clinical research, Molecular Medicine, Neoplasm Recurrence, Local, business, Unrelated Donors, engraftment, medicine.drug, transplantation

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50302dcbac5a2d503a6f92fa5ee20367Test
https://hdl.handle.net/11370/f8202208-23eb-4407-8035-4411c792b23eTest

المؤلفون: Maria-Theresa Krauth, Supratik Basu, Philippe Moreau, Lara Grote, Abraham S. Kanate, Paul G. Richardson, Xin Yu, Ercan Muelduer, Peter D. Byeff, Paula Rodriguez-Otero, Paulo Sérgio Lucio, Tsvetan Biyukov, Pekka Anttila, Sujith Dhanasiri, Münci Yağcı, Alessandra Larocca, Meletios A. Dimopoulos, Nicola Cascavilla, Larisa P. Mendeleeva, Marek Hus, Peter R. E. Johnson, Shien Guo, Katja Weisel, Dina Ben-Yehuda, Filiz Vural, Patrick Hayden

المساهمون: Ege Üniversitesi

المصدر: Leukemialymphoma. 61(8)

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Population, pomalidomide, Dexamethasone, HRQoL, Bortezomib, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Progression-free survival, education, Multiple myeloma, Lenalidomide, education.field_of_study, business.industry, Quality of life, bortezomib, dexamethasone, multiple myeloma, Hematology, Pomalidomide, medicine.disease, humanities, 3. Good health, Thalidomide, 030220 oncology & carcinogenesis, Quality of Life, Neoplasm Recurrence, Local, business, Multiple Myeloma, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd5b37af069eab5dc58348df8930f1eTest
https://pubmed.ncbi.nlm.nih.gov/32268815Test